{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:48:12Z","timestamp":1761511692959},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6521,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1093\/annonc\/mdf050","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:59:57Z","timestamp":1027724397000},"page":"403-411","source":"Crossref","is-referenced-by-count":18,"title":["Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa\/IIIb):a pilot phase I\/II trial"],"prefix":"10.1016","volume":"13","author":[{"given":"C.","family":"P\u00f6ttgen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Eberhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bildat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"St\u00fcben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Stamatis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Hillejan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sohrab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Teschler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Seeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Sack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Stuschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdf050_bb0010","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0039-6109(16)44341-0","article-title":"The role of surgery in N2 lung cancer","volume":"67","author":"Martini","year":"1987","journal-title":"Surg Clin North Am"},{"key":"10.1093\/annonc\/mdf050_bb0015","series-title":"Mediastinal adenopathy\u2014the N2 lesion","first-page":"104","article-title":"International Trends in General Thoracic Surgery","volume":"1","author":"Pearson","year":"1985"},{"key":"10.1093\/annonc\/mdf050_bb0020","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0022-5223(19)35701-0","article-title":"Should subcarinal lymph nodes be routinely examined in patients with non-small-cell lung cancer?","volume":"95","author":"Thomas","year":"1988","journal-title":"Lung Cancer Study Group. J Thorac Cardiovasc Surg"},{"key":"10.1093\/annonc\/mdf050_bb0025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0003-4975(10)64717-0","article-title":"The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis","volume":"46","author":"Naruke","year":"1988","journal-title":"Ann Thorac Surg"},{"issue":"Abstr 823","key":"10.1093\/annonc\/mdf050_bb0030","first-page":"10","article-title":"A phase III study of thoracic irradiation with or without concomitant cisplatin in locoregional unresectable non-small-cell lung cancer (NSCLC): a Hoosier Oncology Group (HOG) protocol","volume":"241","author":"Ansari","year":"1991","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdf050_bb0035","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199202203260805","article-title":"Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer","volume":"326","author":"Schaake-Koning","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdf050_bb0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jnci\/83.6.417","article-title":"Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients","volume":"83","author":"Le Chevalier","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf050_bb0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/jnci\/87.3.198","article-title":"Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer","volume":"87","author":"Sause","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf050_bb0050","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/88.17.1210","article-title":"Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial","volume":"88","author":"Dillman","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf050_bb0055","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1378\/chest.113.1_Supplement.53S","article-title":"Combined-modality treatment of locally advanced non-small-cell lung cancer: incorporation of novel chemotherapeutic agents","volume":"113","author":"Belani","year":"1998","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdf050_bb0060","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small-cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials","volume":"311","author":"Anonymous","year":"1995","journal-title":"BMJ"},{"key":"10.1093\/annonc\/mdf050_bb0065","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2413::AID-CNCR34>3.0.CO;2-Y","article-title":"Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb non-small-cell lung cancer: a meta-analysis","volume":"77","author":"Pignon","year":"1996","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf050_bb0070","doi-asserted-by":"crossref","first-page":"723","DOI":"10.7326\/0003-4819-125-9-199611010-00003","article-title":"Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable non-small-cell lung cancer. A meta-analysis","volume":"125","author":"Pritchard","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdf050_bb0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/83.4.266","article-title":"Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: a phase II study of the Lung Cancer Study Group","volume":"83","author":"Weiden","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf050_bb0080","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1200\/JCO.1992.10.8.1237","article-title":"Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study","volume":"10","author":"Strauss","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf050_bb0085","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0360-3016(93)90388-C","article-title":"Preoperative concomitant cisplatin\/VP16 and radiotherapy in stage III non-small-cell lung cancer","volume":"27","author":"Palazzi","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdf050_bb0090","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/1097-0142(19940815)74:4<1243::AID-CNCR2820740411>3.0.CO;2-D","article-title":"Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small-cell lung cancer","volume":"74","author":"Deutsch","year":"1994","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf050_bb0095","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1200\/JCO.1995.13.8.1880","article-title":"Concurrent cisplatin\/etoposide plus chest radiotherapy followed by surgery for stage IIIa (N2) and IIIb non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805","volume":"13","author":"Albain","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf050_bb0100","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/S0959-8049(96)00248-1","article-title":"Pre-operative chemoradiotherapy in non-small-cell lung cancer stage III patients. Feasibility, toxicity and long-term results of a phase II study","volume":"32A","author":"Favaretto","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdf050_bb0105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1200\/JCO.1997.15.2.712","article-title":"Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer","volume":"15","author":"Choi","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf050_bb0110","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1200\/JCO.1998.16.2.622","article-title":"Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial","volume":"16","author":"Eberhardt","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf050_bb0115","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1200\/JCO.1999.17.4.1185","article-title":"Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer","volume":"17","author":"Thomas","year":"1999","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdf050_bb0120","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/0360-3016(88)90164-2","article-title":"International clinical trials in radiation oncology. The late effects of toxicity scoring","volume":"14","author":"Rubin","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdf050_bb0125","series-title":"Acute radiation morbidity scoring criteria (RTOG)","first-page":"51","article-title":"Principles and Practice of Radiation Oncology","author":"Perez","year":"1993"},{"key":"10.1093\/annonc\/mdf050_bb0130","series-title":"Version","volume":"6","author":"User\u2019s Guide SAS\/STAT","year":"1989"},{"key":"10.1093\/annonc\/mdf050_bb0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1093\/annonc\/mdf050_bb0140","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf050_bb0145","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/sj.bjc.6990693","article-title":"Induction chemotherapy followed by concurrent standard radiotherapy and daily low-dose cisplatin in locally advanced non-small-cell lung cancer","volume":"81","author":"Ardizzoni","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdf050_bb0150","first-page":"161","article-title":"Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial","volume":"350","author":"Saunders","year":"1997","journal-title":"CHART Steering Committee. Lancet"},{"key":"10.1093\/annonc\/mdf050_bb0155","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.1996.14.4.1055","article-title":"Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: Radiation Therapy Oncology Group protocol 91-06","volume":"14","author":"Lee","year":"1996","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdf050_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0169-5002(00)80304-9","article-title":"Phase III comparison of sequential versus concurrent chemoradiation for patients with unresected stage III non-small-cell lung cancer (NSCLC) Report of Radiation Therapy Oncology Group (RTOG) 9410","volume":"29","author":"Curran","year":"2000","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdf050_bb0165","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1200\/JCO.1995.13.2.452","article-title":"Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer","volume":"13","author":"Jeremic","year":"1995","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"10.1093\/annonc\/mdf050_bb0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0360-3016(00)80051-6","article-title":"Biological target volume (BTV) determined with doseresponse data from the correlation between metabolic rate of glucose (MRG) measured with 18F-FDG PET and pathologic complete response (pCR) in stage III non-small-cell lung cancer (NSCLC)","volume":"48","author":"Choi","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdf050_bb0175","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1200\/JCO.2001.19.2.442","article-title":"Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin\/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial","volume":"19","author":"Lau","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf050_bb0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0169-5002(00)00171-9","article-title":"Phase II trail of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer","volume":"31","author":"Ratanatharathorn","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdf050_bb0185","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/1097-0142(20000801)89:3<534::AID-CNCR8>3.0.CO;2-#","article-title":"Induction carboplatin\/paclitaxel followed by concurrent carboplatin\/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA\/B non-small-cell lung carcinoma: a modified phase I trial","volume":"89","author":"Socinski","year":"2000","journal-title":"Cancer"},{"issue":"7","key":"10.1093\/annonc\/mdf050_bb0190","first-page":"43","article-title":"Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC","volume":"14","author":"Choy","year":"2000","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdf050_bb0195","first-page":"2087","article-title":"Different fraction schedules and combinations with chemotherapy in radiation treatment of non-small-cell lung cancer","volume":"20","author":"Brattstrom","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1093\/annonc\/mdf050_bb0200","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1200\/JCO.2000.18.14.2658","article-title":"Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)","volume":"18","author":"Van Zandwijk","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf050_bb0205","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1007\/s002800051083","article-title":"Combined-modality treatment for stage IIIa (N2) non-small-cell lung cancer: a National Cancer Institute Intergroup study","volume":"42","author":"Ettinger","year":"1998","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419609348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419609348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/13\/3\/403\/301026\/mdf050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T07:24:21Z","timestamp":1582183461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419609348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S0923753419609348"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdf050","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}